XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.19.1

Segment information | 3 Months Ended
--- | ---
Mar. 31, 2019
Segment Reporting [Abstract] |
Segment information | Segment information During the first quarter 2019, the chief operating decision maker, or CODM, (the Company's Chief Executive Officer) changed the manner in which he reviews financial information for purposes of assessing business performance and allocating resources by focusing on the geographic location of all non-OEM operations. As a result, the Company changed its segment presentation. Specifically, the Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, Interventional Urology North America, Respiratory North America and Latin America operating segments were combined into a new Americas segment. The Company now has four segments: Americas, EMEA, Asia and OEM. All prior comparative periods presented have been restated to reflect these changes. The following tables present the Company’s segment results for the three months ended March 31, 2019 and April 1, 2018:
| Three Months Ended
| March 31, 2019 |  | April 1, 2018
| (Dollars in thousands)
Americas | $ | 344,024 |  |  | $ | 323,262 |
EMEA | 154,545 |  |  | 159,870 |
Asia | 60,777 |  |  | 58,244 |
OEM | 54,238 |  |  | 45,854 |
Net revenues | $ | 613,584 |  |  | $ | 587,230 |
| Three Months Ended
| March 31, 2019 |  | April 1, 2018
| (Dollars in thousands)
Americas | $ | 65,599 |  |  | $ | 58,890 |
EMEA | 27,023 |  |  | 31,770 |
Asia | 9,979 |  |  | 13,368 |
OEM | 13,321 |  |  | 9,016 |
Total segment operating profit (1) | 115,922 |  |  | 113,044 |
Unallocated expenses (2) | (40,679 | ) |  | (26,201 | )
Income from continuing operations before interest and taxes | $ | 75,243 |  |  | $ | 86,843 |
(1) | Segment operating profit includes segment net revenues from external customers reduced by the segment's standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as net revenues, numbers of employees, and amount of time spent), depending on the category of expense involved.
(2) | Unallocated expenses primarily include manufacturing variances other than fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration